BEVATEM: Phase II study of bevacizumab (B) in combination with temozolomide (T) in patients (pts) with first-line metastatic uveal melanoma (MUM): Final results.
Sophie Piperno-Neumann
No relevant relationships to disclose
Vincent Servois
No relevant relationships to disclose
Francois-Clement Bidard
No relevant relationships to disclose
Pascale Mariani
No relevant relationships to disclose
Corine Plancher
No relevant relationships to disclose
Alhassane Diallo
No relevant relationships to disclose
Nora Vago-Ady
Employment or Leadership Position - Roche
Laurence Desjardins
No relevant relationships to disclose